Trinitrobenzene sulfonic acid (TNBS) treatment, which is used in animals to induce colitis-like gut inflammation, leads to increased brain TNF-α and reduced memory performance in mice, supporting an association of gut–brain interaction, elevated brain TNF-α, and decreased memory [44]. The gene discussed is TNF; the disease is colitis.